Literature DB >> 17976100

Cardiac resynchronization therapy response is associated with shorter duration of atrial fibrillation.

Nicolas Lellouche1, Carlos De Diego, Marmar Vaseghi, Eric Buch, David A Cesario, Aman Mahajan, Isaac Wiener, Gregg C Fonarow, Noel G Boyle, Kalyanam Shivkumar.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is commonly associated with heart failure. The benefit of cardiac resynchronization therapy (CRT) on atrial remodeling has been demonstrated. However, biventricular pacing did not reduce the global incidence of AF. We evaluated the relationship between CRT response and AF duration.
METHODS: We retrospectively analyzed data from 96 patients (59 +/- 15 years; 78% male) who underwent CRT. All patients had class III-IV New York Heart Association (NYHA) symptoms despite maximal medical therapy, left ventricular ejection fraction (LVEF) < or = 35%, QRS >130 ms, and sinus rhythm before implantation. CRT response in patients who survived at six months of follow-up was defined as: (1) no hospitalization for heart failure and (2) improvement of one or more grades in the NYHA classification.
RESULTS: CRT responders (n = 54) and non-responders (n = 42) had similar baseline characteristics, including the incidence of persistent AF within six months before implantation. Six months after implantation, when compared to baseline, CRT responders exhibited a significant decrease in left atrial size (47.5 +/- 7.1 mm vs 44.6 +/- 7.7 mm, P < 0.01) and in the incidence of persistent AF (17% vs 2%, P = 0.02). At six months, CRT responders demonstrated shorter mean AF duration (7.5 +/- 43.3 hours vs 48.8 +/- 129.0 hours, P = 0.03) and lower incidence of persistent AF (2% vs 19%, P = 0.004) compared to nonresponders.
CONCLUSION: CRT response is associated with a reversal of atrial remodeling and a shorter AF duration.

Entities:  

Mesh:

Year:  2007        PMID: 17976100     DOI: 10.1111/j.1540-8159.2007.00872.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  10 in total

1.  Clinical application of pacemakers in atrial tachyarrhythmias.

Authors:  W G de Voogt; N M van Hemel
Journal:  Neth Heart J       Date:  2008-10       Impact factor: 2.380

2.  Nonpharmacological Treatment of Atrial Fibrillation: What Is the Role of Device Therapy?

Authors:  Lucie Riedlbauchová; Václav Durdil; Jakub Honěk; Josef Veselka
Journal:  Int J Angiol       Date:  2020-04-28

Review 3.  Is cardiac resynchronization therapy an antiarrhythmic therapy for atrial fibrillation? A systematic review and meta-analysis.

Authors:  Paul L Hess; Kevin P Jackson; Vic Hasselblad; Sana M Al-Khatib
Journal:  Curr Cardiol Rep       Date:  2013-02       Impact factor: 2.931

4.  Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.

Authors:  Prateeti Khazanie; Melissa A Greiner; Sana M Al-Khatib; Jonathan P Piccini; Mintu P Turakhia; Paul D Varosy; Frederick A Masoudi; Lesley H Curtis; Adrian F Hernandez
Journal:  Circ Heart Fail       Date:  2016-06       Impact factor: 8.790

Review 5.  Atrial fibrillation and congestive heart failure.

Authors:  Noel G Boyle; Kalyanam Shivkumar
Journal:  Curr Heart Fail Rep       Date:  2008-03

6.  Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes.

Authors:  Celestino Sardu; Michelangela Barbieri; Matteo Santamaria; Valerio Giordano; Cosimo Sacra; Pasquale Paolisso; Alessandro Spirito; Raffaele Marfella; Giuseppe Paolisso; Maria Rosaria Rizzo
Journal:  Cardiovasc Diabetol       Date:  2017-06-09       Impact factor: 9.951

7.  Predictors of rhythm outcomes after cardiac resynchronization therapy in atrial fibrillation patients: When should we use an atrial lead?

Authors:  Sotirios Nedios; Michael Doering; Angeliki Darma; Johannes Lucas; Borislav Dinov; Arash Arya; Nikolaos Dagres; Gerhard Hindricks; Andreas Bollmann; Sergio Richter; Kerstin Bode
Journal:  Clin Cardiol       Date:  2020-12-09       Impact factor: 2.882

8.  Atrial fibrillation associated with heart failure treated by a 2-lead CRT-DX system (BIO-AffectDX): Study design and clinical protocol.

Authors:  Jonathan C Hsu; Aaron B Hesselson; Jackson J Liang; Stavros Mountantonakis; Gregory T David; Alexandru Costea
Journal:  Heart Rhythm O2       Date:  2021-10-09

9.  Pacemaker and Atrioventricular Junction Ablation in Patients With Atrial Fibrillation-A Systematic Review of Systematic Review and Meta-Analysis.

Authors:  Chi Zhang; Xi-Ying Wang; Lian Lou; Xuan Zhang; Le-Le Chen; Yu-Xiao Chen; Jian Yang
Journal:  Front Cardiovasc Med       Date:  2022-01-20

Review 10.  The Role of Cardiac Resynchronization Therapy for the Management of Functional Mitral Regurgitation.

Authors:  Eleonora Russo; Giulio Russo; Mauro Cassese; Maurizio Braccio; Massimo Carella; Paolo Compagnucci; Antonio Dello Russo; Michela Casella
Journal:  Cells       Date:  2022-08-04       Impact factor: 7.666

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.